Fleming, G. F., Sill, M. W., Darcy, K. M., McMeekin, D. S., Thigpen, J. T., Adler, L. M., . . . Fiorica, J. V. (2009). Phase II Trial of Trastuzumab in Women with Advanced or Recurrent, HER2-Positive Endometrial Carcinoma: A Gynecologic Oncology Group Study.
Citação norma ChicagoFleming, Gini F., et al. Phase II Trial of Trastuzumab in Women With Advanced or Recurrent, HER2-Positive Endometrial Carcinoma: A Gynecologic Oncology Group Study. 2009.
ציטוט MLAFleming, Gini F., et al. Phase II Trial of Trastuzumab in Women With Advanced or Recurrent, HER2-Positive Endometrial Carcinoma: A Gynecologic Oncology Group Study. 2009.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.